rs201593811

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2

The NM_004836.7(EIF2AK3):​c.154G>A​(p.Ala52Thr) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00468 in 1,502,868 control chromosomes in the GnomAD database, including 21 homozygotes. In-silico tool predicts a benign outcome for this variant. 13/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★). Synonymous variant affecting the same amino acid position (i.e. A52A) has been classified as Likely benign.

Frequency

Genomes: 𝑓 0.0036 ( 1 hom., cov: 33)
Exomes 𝑓: 0.0048 ( 20 hom. )

Consequence

EIF2AK3
NM_004836.7 missense

Scores

1
1
16

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:13

Conservation

PhyloP100: 1.56

Publications

12 publications found
Variant links:
Genes affected
EIF2AK3 (HGNC:3255): (eukaryotic translation initiation factor 2 alpha kinase 3) The protein encoded by this gene phosphorylates the alpha subunit of eukaryotic translation-initiation factor 2, leading to its inactivation, and thus to a rapid reduction of translational initiation and repression of global protein synthesis. This protein is thought to modulate mitochondrial function. It is a type I membrane protein located in the endoplasmic reticulum (ER), where it is induced by ER stress caused by malfolded proteins. Mutations in this gene are associated with Wolcott-Rallison syndrome. [provided by RefSeq, Sep 2015]
EIF2AK3 Gene-Disease associations (from GenCC):
  • Wolcott-Rallison syndrome
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Genomics England PanelApp, G2P, Labcorp Genetics (formerly Invitae), Ambry Genetics, Orphanet

Genome browser will be placed here

new If you want to explore the variant's impact on the transcript NM_004836.7, check out the Mutation Effect Viewer. This is especially useful for frameshift variants or if you want to visualize the effect of exon loss / intron retention.

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.0064079165).
BP6
Variant 2-88627121-C-T is Benign according to our data. Variant chr2-88627121-C-T is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 193296.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population nfe. GnomAd4 allele frequency = 0.00359 (546/152088) while in subpopulation NFE AF = 0.00577 (392/67958). AF 95% confidence interval is 0.0053. There are 1 homozygotes in GnomAd4. There are 267 alleles in the male GnomAd4 subpopulation. Median coverage is 33. This position passed quality control check.
BS2
High Homozygotes in GnomAdExome4 at 20 AR gene

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_004836.7. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
EIF2AK3
NM_004836.7
MANE Select
c.154G>Ap.Ala52Thr
missense
Exon 1 of 17NP_004827.4

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
EIF2AK3
ENST00000303236.9
TSL:1 MANE Select
c.154G>Ap.Ala52Thr
missense
Exon 1 of 17ENSP00000307235.3Q9NZJ5
EIF2AK3
ENST00000682892.1
c.-145-13268G>A
intron
N/AENSP00000507214.1A0A804HIT4
EIF2AK3
ENST00000652099.1
n.151G>A
non_coding_transcript_exon
Exon 1 of 18ENSP00000498211.1A0A494BZR8

Frequencies

GnomAD3 genomes
AF:
0.00358
AC:
544
AN:
151980
Hom.:
1
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.00101
Gnomad AMI
AF:
0.00658
Gnomad AMR
AF:
0.00131
Gnomad ASJ
AF:
0.000577
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00310
Gnomad FIN
AF:
0.00599
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00577
Gnomad OTH
AF:
0.00192
GnomAD2 exomes
AF:
0.00460
AC:
443
AN:
96344
AF XY:
0.00483
show subpopulations
Gnomad AFR exome
AF:
0.00133
Gnomad AMR exome
AF:
0.00290
Gnomad ASJ exome
AF:
0.000147
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00863
Gnomad NFE exome
AF:
0.00703
Gnomad OTH exome
AF:
0.00830
GnomAD4 exome
AF:
0.00480
AC:
6483
AN:
1350780
Hom.:
20
Cov.:
30
AF XY:
0.00472
AC XY:
3147
AN XY:
666292
show subpopulations
African (AFR)
AF:
0.000868
AC:
24
AN:
27652
American (AMR)
AF:
0.00277
AC:
89
AN:
32170
Ashkenazi Jewish (ASJ)
AF:
0.000168
AC:
4
AN:
23836
East Asian (EAS)
AF:
0.00
AC:
0
AN:
31406
South Asian (SAS)
AF:
0.00312
AC:
237
AN:
76054
European-Finnish (FIN)
AF:
0.00984
AC:
340
AN:
34558
Middle Eastern (MID)
AF:
0.00292
AC:
12
AN:
4106
European-Non Finnish (NFE)
AF:
0.00521
AC:
5546
AN:
1064782
Other (OTH)
AF:
0.00411
AC:
231
AN:
56216
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.508
Heterozygous variant carriers
0
410
820
1231
1641
2051
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
196
392
588
784
980
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00359
AC:
546
AN:
152088
Hom.:
1
Cov.:
33
AF XY:
0.00359
AC XY:
267
AN XY:
74374
show subpopulations
African (AFR)
AF:
0.00101
AC:
42
AN:
41552
American (AMR)
AF:
0.00138
AC:
21
AN:
15270
Ashkenazi Jewish (ASJ)
AF:
0.000577
AC:
2
AN:
3468
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5174
South Asian (SAS)
AF:
0.00331
AC:
16
AN:
4834
European-Finnish (FIN)
AF:
0.00599
AC:
63
AN:
10520
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
292
European-Non Finnish (NFE)
AF:
0.00577
AC:
392
AN:
67958
Other (OTH)
AF:
0.00190
AC:
4
AN:
2108
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.494
Heterozygous variant carriers
0
26
52
77
103
129
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00511
Hom.:
0
Bravo
AF:
0.00287

ClinVar

ClinVar submissions
Significance:Benign/Likely benign
Revision:criteria provided, multiple submitters, no conflicts
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
4
not provided (4)
-
-
3
not specified (3)
-
-
3
Wolcott-Rallison dysplasia (3)
-
-
1
Connective tissue disorder (1)
-
-
1
EIF2AK3-related disorder (1)
-
-
1
Monogenic diabetes (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.21
BayesDel_addAF
Benign
-0.32
T
BayesDel_noAF
Benign
-0.23
CADD
Uncertain
24
DANN
Uncertain
0.98
DEOGEN2
Benign
0.13
T
Eigen
Benign
-0.61
Eigen_PC
Benign
-0.61
FATHMM_MKL
Benign
0.12
N
LIST_S2
Benign
0.58
T
MetaRNN
Benign
0.0064
T
MetaSVM
Benign
-0.83
T
MutationAssessor
Benign
1.5
L
PhyloP100
1.6
PrimateAI
Pathogenic
0.86
D
PROVEAN
Benign
-0.25
N
REVEL
Benign
0.069
Sift
Benign
0.19
T
Sift4G
Benign
0.31
T
PromoterAI
-0.0046
Neutral
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.2
Varity_R
0.078
gMVP
0.40
Mutation Taster
=98/2
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

MaxEntScan Visualizer can be used to analyze the impact of this mutation on the neighboring sequence.

Publications

Other links and lift over

dbSNP: rs201593811;
hg19: chr2-88926639;
COSMIC: COSV108144621;
COSMIC: COSV108144621;
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.